Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
Published on: October 25, 2024
Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis
Edward Cabral1, Mary Katherine Montgomery1, Meaghan Berg2
1Drug Safety R&D, Discovery & Early Development, Pfizer, Inc.
Abstract:
Positron Emission Tomography (PET) is a molecular imaging modality that can be used to investigate a multitude of pharmacological questions, such as biomarker modulation, receptor occupancy, and biodistribution of compounds of interest. In biodistribution studies, experimental subjects are often longitudinally imaged after receiving the test article. The images are then analyzed to derive the compound's distribution profile in various organs at different timepoints. This constitutes a crucial step in drug development to understand the distribution and potentially binding profile of an investigative compound. Standard/manual methods of PET imaging-based biodistribution analyses, however, are labor-intensive and time-consuming and are often associated with high inter-operator variability. Further, it is challenging to keep the animals' positions consistent across different timepoints. To address these shortcomings, a series of mouse Body Conforming Animal Molds (BCAMs) were used to enable rigid and consistent positioning of animals during PET/CT imaging acquisition. Further, a Software-as-a-Service (SaaS) platform consisting of a cloud-based Organ Probability Map (OPM) and an artificial intelligence-powered segmentation tool were employed to enable reliable and automated quantitation of in vivo PET imaging data. The workflow presented here includes (1) prepping mice for imaging with the BCAMs, including the proper implantation of subcutaneous tumors to be compatible with the molds, (2) acquiring PET/CT images with BCAMs using the G8 scanner, and 3) performing automated organ segmentation and biodistribution analysis using the cloud-based SaaS. [18F]FDG was used as an exemplar tracer here, but other biomarkers and/or radio-labeled compounds can be readily adapted into the workflow. This procedure can be executed accurately and effectively with minimal training, and the automated PET data analysis yielded satisfactory results consistent with the manual method.
Insights
This study introduces a new workflow using Body Conforming Animal Molds (BCAMs) and a Software-as-a-Service (SaaS) platform for automated Positron Emission Tomography (PET) biodistribution analysis in mice. The method ensures consistent animal positioning and accurate, efficient data quantitation.
Area of Science:
- Molecular imaging
- Pharmacological research
- Drug development
Background:
- Positron Emission Tomography (PET) is vital for drug development, assessing biomarker modulation, receptor occupancy, and compound biodistribution.
- Manual PET biodistribution analysis is labor-intensive, time-consuming, and prone to inter-operator variability and inconsistent animal positioning.
- Consistent animal positioning is critical for accurate longitudinal imaging and biodistribution profiling.
Purpose of the Study:
- To develop and validate an automated workflow for in vivo PET imaging-based biodistribution analysis in mice.
- To address limitations of manual analysis, including labor intensity, time consumption, and operator variability.
- To enhance the reliability and efficiency of drug distribution profiling using PET.
Main Methods:
- Utilized mouse Body Conforming Animal Molds (BCAMs) for rigid and consistent animal positioning during PET/CT acquisition.
- Employed a Software-as-a-Service (SaaS) platform with a cloud-based Organ Probability Map (OPM) and AI-powered segmentation.
- Integrated BCAMs with PET/CT imaging and automated analysis for organ segmentation and biodistribution quantitation.
Main Results:
- The BCAMs ensured consistent animal positioning, facilitating reproducible imaging.
- The SaaS platform enabled automated, reliable organ segmentation and biodistribution analysis.
- Automated analysis yielded results comparable to manual methods, demonstrating accuracy and efficiency.
Conclusions:
- The presented workflow, combining BCAMs and SaaS, offers an accurate and effective solution for automated PET biodistribution analysis.
- This automated approach significantly reduces labor, time, and inter-operator variability compared to manual methods.
- The workflow is adaptable for various tracers and can be executed with minimal training, streamlining drug development processes.
More Related Videos
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022